Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diageo plc (DEO) vs Tilray Brands Inc (TLRY) Price & Performance

Diageo plcTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Diageo plc vs Tilray Brands Inc — how do they compare? Diageo plc trades at $81.01 (market cap $45.41B), while Tilray Brands Inc trades at $4.37 (market cap $540.74M). The key difference: Diageo plc is far larger — about 84× Tilray Brands Inc's market cap, and Diageo plc pays a 4.02% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.

DEOTLRY
Market Cap
$45.41B$540.74M
Sector
TechnologyHealth
52-Week High
$115.33$21.00
52-Week Low
$72.47$4.31
Enterprise Value
$66.23B$637.89M
Dividend Yield
4.02%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Diageo plc

No Aura AI signal available yet.

Tilray Brands Inc

TLRY trades at $4.46, up 0.9% on the day, amid a bearish technical signal and mixed earnings history. The company reported a net loss of $2.19 billion in 2025, with a negative net income margin of -156.67%, though revenue grew to $821.31 million. Analyst consensus is cautious with 65% hold ratings, and recent news highlights expansion in medical cannabis and new product launches.

The outlook remains challenged by persistent losses and high debt levels, but low valuation ratios like P/S of 0.54 and P/B of 0.35 may attract value investors. Key risks include profitability struggles and regulatory uncertainty, while potential catalysts include international expansion and upcoming earnings on July 28, 2026.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Diageo plc

Diageo is a global leader in beverage alcohol with an outstanding collection of brands including Johnnie Walker, Smirnoff, and Guinness. It operates a vast portfolio of spirits and beers across more than 180 countries.

Read more on DEO

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY